Chronic hepatitis C infection in children

Minerva Gastroenterologica e Dietologica

Volumn 52, Issue 2, 2006, Pages 187-193

  Broide, E ^a,b   Kimchi, N A ^a   Scapa, E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Child; Hepatitis C virus infections, diagnosis; Hepatitis C virus infections, therapy

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; IMMUNOGLOBULIN; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ALLERGIC REACTION; ALOPECIA; ARTICLE; BLOOD TRANSFUSION; BREAST FEEDING; CHILL; CLINICAL FEATURE; CLINICAL TRIAL; DIARRHEA; DISEASE COURSE; DOSE RESPONSE; FEBRILE CONVULSION; FEVER; GEOGRAPHY; HAND PARESTHESIA; HEADACHE; HEART FAILURE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HISTORY; HOUSEHOLD; HUMAN; INFECTION RISK; LIVER DISEASE; MALAISE; MYALGIA; NEUTROPENIA; PRURITUS; SEXUAL TRANSMISSION; SIDE EFFECT; THROMBOCYTOPENIA; VIRUS TRANSMISSION; WEIGHT REDUCTION;

CHILD; HEPATITIS C, CHRONIC; HUMANS;

EID: 33646824885     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. CID 2000;36:275-80.
2. Sehgal S, Allen PLJ. Hepatitis C in children. Pediatric Nursing 2004;30:409-13.
3. Tovo PA Newell ML. Hepatitis C in children. Curr Opin Infect Dis 1999;12:245-50.
4. Schwimmer JB, Balistreri WF. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Seminars in Liver Disease 2000;20:37-46.
5. American Academy of Pediatrics-Committee on Infectious Diseases. Hepatitis C Virus Infection. Pediatrics 1998;101:481-5.
6. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F et al. The prevalence of Hepatitis C Virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
7. Lisewska IM, Slzewski W, Youseif KA, Figlerowicz M, Piaskowska AK. Virus genotype Ib and long term response to interferon alpha monotherapy in children with chronic hepatitis C. Eur. J. Pediatr 2003;162:755-9.
8. Henderson DK. Managing occupational risks for hepatitis C transmission in the health care setting. Clinical Microbiology Review 2003;16:546-68.
9. Management of hepatitis C. NIH Consensus Statement Online 1997;15:1-41.
10. Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration-United States, October 1993-June 1994. MMWR 1999;43:505-509.
11. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C et al. Transmission of hepatitis C from mothers to infants. The vertical transmission of hepatitis C virus collaborative study group. N Engl J Med 1994;330: 744-50.
12. Resti M, Azzari C, Mannelli F, Moriondo M, Novembre E, de Martino M et al. Mother-to-child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children bom to women seronegative for HIV-1. BMJ 1998; 317: 437-41.
13. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995;341:289-91.
14. Paccagnini S, Principi N, Massironi E, Tanzi E, Romano L, Muggiasca ML et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995;14:195-199.
15. Saez A, Losa M, Lo Iacono, Lozano C, Alvarez E, Pita L, Garcia-Monzon C. Diagnostic and prognostic value of virologie tests in vertical transmission of hepatitis C virus infection: results of a large prospective study in pregnant women. Hepatogastroenterology 2004;51: 1104-8.
16. Pembreya L, Newella ML, Tovo PA, EPHN Collaboration. The management of HCV infected pregnant women and their children European pediatric HCV network. J Hepatol 2005;43:515-25.
17. European pediatric hepatitis c virus network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005;192:1872-9.
18. Centers for Disease Control and Prevention. Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissue, and semen for evidence of hepatitis B and hepatitis C. Morb Mortal Wkly Rep 1991;40:1-17.
19. Lin HH, Kao JH, Hsu HY, Ni YH, Chang MH, Huang SC et al. Absence of infection in breast -fed infants born to hepatitis C virus-infected mothers. J Pediatr 1995;126: 589-91.
20. Kumar RM, Shaul S. Role of breast feeding in transmission of hepatitis C virus to infant of HCV- infected mothers.J Hepatol 1998;29:191-7.
21. Osmond DH, Padian NS, Sheppard HW, Glass S, Shiboski SC, Reingold A. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 1993;269:361-5.
22. Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV et al. Sexual transmission of hepatitis C virus among patients attendimg sexually transmitted diseases clinics in Baltimore-an analysis of 309 sex partnerships. J Infect Dis. 1995;171:768-775.
23. Steeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36:S35-46.
24. Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. CID 2000;36:275-80.
25. Iorio R, Pensanti P, Botta S, Moschella S, Impagliazzo N, Vajro P et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997;16:984-90.
26. Ruiz-Moreno M, Leak-Orozco A, Millan A. Hepatitis C virus infection in children. J Hepatol 1999; 31: (Suppl 1): 124-9.
27. Tovo PA, Pembrey LJ, Newell ML. European Pediatric Hepatitis C Virus infection Network. Persistence rate and progression of vertically acquired hepatitis C infection JID 2000; 181: 419-24.
28. Locasciulli A, Gornati G, Tagger A, Ribero ML, Cavaletto D, Cavaletto L et al. Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. Blood 1991;78:1619-22.
29. Strickland DK, Riely CA, Patrick CC, Wallace DJ, Boyett JM, Waters B et al. Hepatitis C infection among survivors of childhood cancer. Blood 2000;15;95:3065-70.
30. Garcia-Monzon C, Jara P, Fernandez-Bermejo M, Hierro L, Frauca E, Camarena C et al. Chronic hepatits C in children: A clinical and immunohistochemical comparative study with adult patients. Hepatology 1998;28: 1696-701.
31. Bortolotti F, Resti M, Giacchino R, Azzari C, Gussetti N, Crivellaro C et al. Hepatitis C virus infection and relat-ed liver disease in children of mothers with antibodies to the virus. J Pediatr 1997;130:990-3.
32. Matsuoka S, Tatara K, Hayabuchi Y, Nu M, Mori K, Kuroda Y. Post-transfusion chronic hepatitis C in children. J Pediatr. Child. Health 1994;30:544-6.
33. Guido M, Bortolotti F, Leandro G, Jara P, Hierro L, Larrauri J et al. Fibrosis in chronic hepatitis C acquired in infancy: is it a matter of time? Am J gastroenterol 2003;98:660-3.
34. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-11.
35. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the united states. Hepatology 2003;36:74-83.
36. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Sem Liver Dis 1995;15:70-81.
37. Lai ME, De Virgilis S, Argiolu F, Farci P, Mazzoleni AP, Lisci V et al. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between rst- and second-generation assay. J Pediatr Gastroenterol Nutr 1993;16:458-64.
38. Badizadegan K, Jonas MM, Ott MJ, Nelson SP, Perez-Atayde AR. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
39. Kage M, Fujisawa T, Shiraki K, Tanaka T, Fujisawa T, Kimura A, Shimamatsu K et al. Pathology of chronic hepatitis C in children. Hepatology 1997;26:771-5.
40. Iorio R, Guida S, Porzio S, Fariello I, Vegnente A. Chronic non-Á, non-B hepatitis: Role of hepatitis C virus. Arch Dis Child 1993;68:219-22.
41. Boitolotti F, Vajro P, Cadrobbi P, Lepore L, Zancan L, Barbera C et al. Cryptogenic chronic liver disease and hepatitis C virus infection in children. J Hepatol 1992;15:73-6.
42. Guido M, Rugge M, Jara P, Hierro L, Giacchino R, Larrauri J et al. Chronic hepatitis C in children: The pathological and clinical spectrum. Gastroenterology 1998;115:1525-9.
43. Broide E, Reif S, Brazovski E, Shapira R, Weiss B, Bujanover Y. Chronic Hepatitis C in Israeli children. Fetal and Pediatric Pathology 2004;23:231-9.
44. Mozer-Lisewska I, Sluzewski W, Ali Yousef K, Figlerowicz M, Kowala-Piaskowska A. Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C. Eur J Pediatr 2003;162:755-9.
45. Wirht S, Pieper-Boustani H, Lang T, Ballauf A, Kullmer U, Gerner P et al. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 2005;41:1013-8.
46. Figlerowicz M, Sluzewski W, Kowala-Piaskowska A, Mozer-Lisewska I. Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C. Eur J Pediatr 2004;163:265-7.
47. Younossi ZM, Singer ME, McHutchison JG, Shermock KM. Cost effectiveness of interferon- alpha 2b combined with ribavirine for the treatment in of chronic hepatitis C. Hepatology 1999;30:1318-24.
48. Jacobson KR, Murray K, Zellos A, Schwarz KB. An analysis of published trials of Interferon monotherapy in children with chronic hepatitis C. JPGN 2002;34:52-8.
49. Tong MJ, El-Forra NS, Reikes AR. Clinical outcomes after transmission-associated hepatitis C. N Engl J Med 1995;332:1463-6.
50. Puetz J, Thrower M, Kane R, Bouhasin J. Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilic treatment center. Haemophilia 2004;10:87-93.
51. Süoglu OD, Elkabes B, Sökücü S, Saner G. Does interferon and ribavirin combination therapy increase the rate of treatment response in children with hepatitis C? JPGN 2002;34:199-206.
52. Lackner H, Moser A, Deutsch J. Interferon-( and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatr 2000;106:e53-59.
53. Christensson B, Wiebe T, Akesson A, Widell A. Interferon-( and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis 2000;30:585-6.
54. Fried MW, Peter J, Hoots K, Gaglio PJ, Talbut D, Davis PC et al. Hepatitis C in adults and adolescents with hemophilia and inherited disorders of coagulation: a randomized controlled, multicenter trial of combination therapy with interferon alpha-2b and ribavirin. Hepatology 2002;36:967-72.
55. Manns MP, McHutchinson JG, Gordon SG, Rustgi VK, Shiffman M, Reindollar R et al. Peginterferon alpha 2b plus ribavirine compared with interferon alpha 2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001;358:958-65.
56. Hartman C, Berkowitz D, Rimon N , Shamir R. The effect of early treatment in children with chronic hepatitis. JPGN 2003;37:252-7.
57. Gottrand F, Michaud L, Guimber D, Ategbo S, Dubar G, Turck D, Farriaux JP. Influence of recombinant interferon alpha on nutritional status and growth pattern in children with chronic viral hepatitis. Eur J Pediatr 1996;155:1031-4.